167 related articles for article (PubMed ID: 22978414)
1. PNPLA 3 I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection.
Rembeck K; Maglio C; Lagging M; Christensen PB; Färkkilä M; Langeland N; Buhl MR; Pedersen C; Mørch K; Norkrans G; Hellstrand K; Lindh M; Pirazzi C; Burza MA; Romeo S; Westin J;
BMC Med Genet; 2012 Sep; 13():82. PubMed ID: 22978414
[TBL] [Abstract][Full Text] [Related]
2. The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C.
Manchiero C; Nunes AKDS; Magri MC; Dantas BP; Mazza CC; Barone AA; Tengan FM
BMC Infect Dis; 2017 Dec; 17(1):780. PubMed ID: 29258449
[TBL] [Abstract][Full Text] [Related]
3. PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis C.
Ampuero J; Del Campo JA; Rojas L; García-Lozano JR; Solá R; Andrade R; Pons JA; Navarro JM; Calleja JL; Buti M; González-Escribano MF; Forns X; Diago M; García-Samaniego J; Romero-Gómez M
Ann Hepatol; 2014; 13(4):356-63. PubMed ID: 24927606
[TBL] [Abstract][Full Text] [Related]
4. Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C.
Zampino R; Coppola N; Cirillo G; Boemio A; Pisaturo M; Marrone A; Macera M; Sagnelli E; Perrone L; Adinolfi LE; Miraglia del Giudice E
J Viral Hepat; 2013 Aug; 20(8):517-23. PubMed ID: 23808989
[TBL] [Abstract][Full Text] [Related]
5. Interaction between PNPLA3 I148M variant and age at infection in determining fibrosis progression in chronic hepatitis C.
De Nicola S; Dongiovanni P; Aghemo A; Cheroni C; D'Ambrosio R; Pedrazzini M; Marabita F; Donnici L; Maggioni M; Fargion S; Colombo M; De Francesco R; Valenti L
PLoS One; 2014; 9(8):e106022. PubMed ID: 25171251
[TBL] [Abstract][Full Text] [Related]
6. Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis.
Cai T; Dufour JF; Muellhaupt B; Gerlach T; Heim M; Moradpour D; Cerny A; Malinverni R; Kaddai V; Bochud M; Negro F; Bochud PY
J Hepatol; 2011 Sep; 55(3):529-535. PubMed ID: 21236304
[TBL] [Abstract][Full Text] [Related]
7. Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.
Valenti L; Maggioni P; Piperno A; Rametta R; Pelucchi S; Mariani R; Dongiovanni P; Fracanzani AL; Fargion S
World J Gastroenterol; 2012 Jun; 18(22):2813-20. PubMed ID: 22719190
[TBL] [Abstract][Full Text] [Related]
8. Association between PNPLA3[G]/I148M variant, steatosis and fibrosis stage in hepatitis C virus - genetic matters.
Crisan D; Grigorescu M; Crisan N; Craciun R; Lupsor M; Radu C; Grigorescu MD; Suciu A; Epure F; Avram L; Leach N
J Physiol Pharmacol; 2019 Aug; 70(4):. PubMed ID: 31642820
[TBL] [Abstract][Full Text] [Related]
9. Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin.
Valenti L; Aghemo A; Stättermayer AF; Maggioni P; De Nicola S; Motta BM; Rumi MG; Dongiovanni P; Ferenci P; Colombo M; Fargion S
Aliment Pharmacol Ther; 2012 Jun; 35(12):1434-42. PubMed ID: 22530607
[TBL] [Abstract][Full Text] [Related]
10. No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV.
Nakamura M; Kanda T; Nakamoto S; Miyamura T; Jiang X; Wu S; Yokosuka O
PLoS One; 2013; 8(12):e81312. PubMed ID: 24349054
[TBL] [Abstract][Full Text] [Related]
11. Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C.
Sagnelli C; Merli M; Uberti-Foppa C; Hasson H; Cirillo G; Grandone A; Salpietro S; Minichini C; Del Giudice EM; Lazzarin A; Sagnelli E; Coppola N
Clin Microbiol Infect; 2016 Apr; 22(4):372-378. PubMed ID: 26806136
[TBL] [Abstract][Full Text] [Related]
12. Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant.
Palmer CN; Maglio C; Pirazzi C; Burza MA; Adiels M; Burch L; Donnelly LA; Colhoun H; Doney AS; Dillon JF; Pearson ER; McCarthy M; Hattersley AT; Frayling T; Morris AD; Peltonen M; Svensson PA; Jacobson P; Borén J; Sjöström L; Carlsson LM; Romeo S
PLoS One; 2012; 7(6):e39362. PubMed ID: 22724004
[TBL] [Abstract][Full Text] [Related]
13. Role of PNPLA3 in the Assessment and Monitoring of Hepatic Steatosis and Fibrosis in Patients with Chronic Hepatitis C Infection Who Achieved a Sustained Virologic Response.
Gavril OI; Arhire LI; Gavrilescu O; Dranga M; Barboi O; Gavril RS; Popescu R; Cijevschi Prelipcean C; Trifan AV; Mihai C
Medicina (Kaunas); 2021 Oct; 57(11):. PubMed ID: 34833371
[No Abstract] [Full Text] [Related]
14. Improvement of liver fibrosis, but not steatosis, after HCV eradication as assessment by MR-based imaging: Role of metabolic derangement and host genetic variants.
Chuaypen N; Siripongsakun S; Hiranrat P; Tanpowpong N; Avihingsanon A; Tangkijvanich P
PLoS One; 2022; 17(6):e0269641. PubMed ID: 35696400
[TBL] [Abstract][Full Text] [Related]
15. Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance.
Rametta R; Ruscica M; Dongiovanni P; Macchi C; Fracanzani AL; Steffani L; Fargion S; Magni P; Valenti L
Eur J Clin Invest; 2014 Jul; 44(7):627-33. PubMed ID: 24828988
[TBL] [Abstract][Full Text] [Related]
16. TM6SF2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA3 polymorphism.
Coppola N; Rosa Z; Cirillo G; Stanzione M; Macera M; Boemio A; Grandone A; Pisaturo M; Marrone A; Adinolfi LE; Sagnelli E; Miraglia del Giudice E
Liver Int; 2015 Aug; 35(8):1959-63. PubMed ID: 25581573
[TBL] [Abstract][Full Text] [Related]
17. The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls.
Valenti L; Rametta R; Ruscica M; Dongiovanni P; Steffani L; Motta BM; Canavesi E; Fracanzani AL; Mozzi E; Roviaro G; Magni P; Fargion S
BMC Gastroenterol; 2012 Aug; 12():111. PubMed ID: 22898488
[TBL] [Abstract][Full Text] [Related]
18. The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection.
Clark PJ; Thompson AJ; Zhu Q; Vock DM; Zhu M; Patel K; Harrison SA; Naggie S; Ge D; Tillmann HL; Urban TJ; Shianna K; Fellay J; Goodman Z; Noviello S; Pedicone LD; Afdhal N; Sulkowski M; Albrecht JK; Goldstein DB; McHutchison JG; Muir AJ
Dig Dis Sci; 2012 Aug; 57(8):2213-21. PubMed ID: 22543885
[TBL] [Abstract][Full Text] [Related]
19. PNPLA3 rs738409 G allele carriers with genotype 1b HCV cirrhosis have lower viral load but develop liver failure at younger age.
Senkerikova R; Frankova S; Jirsa M; Kreidlova M; Merta D; Neroldova M; Chmelova K; Spicak J; Sperl J
PLoS One; 2019; 14(9):e0222609. PubMed ID: 31527889
[TBL] [Abstract][Full Text] [Related]
20. Four-Week Omega-3 Supplementation in Carriers of the Prosteatotic PNPLA3 p.I148M Genetic Variant: An Open-Label Study.
Kuttner CS; Mancina R; Wagenpfeil G; Lammert F; Stokes CS
Lifestyle Genom; 2019; 12(1-6):10-17. PubMed ID: 31454802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]